biomodal

biomodal is a Cambridge-based life sciences technology company developing multiomics sequencing solutions that simultaneously capture genetic and epigenetic information from a single DNA sample.

Its multiomics platform detects the canonical four DNA bases alongside 5-methylcytosine and 5-hydroxymethylcytosine modifications at single-base resolution, without requiring additional hardware or bisulfite treatment.

The technology is compatible with existing sequencing infrastructure and targets applications in oncology, neurodegenerative disease research, and liquid biopsy diagnostics.